目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 BIOACTIVE DRESSINGS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 3: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.4.1 GROWTH RATE ASSUMPTIONS
2.4.2 LIMITATIONS
2.5 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 47)

4 PREMIUM INSIGHTS (Page No. - 51)
4.1 BIOACTIVE DRESSINGS MARKET OVERVIEW
4.2 BIOACTIVE DRESSINGS INDUSTRY SHARE, BY PRODUCT, 2024 VS. 2029
4.3 MARKET SHARE, BY TYPE, 2024 VS. 2029
4.4 SKIN SUBSTITUTES MARKET SHARE, BY TYPE, 2024 VS. 2029
4.5 MARKET SHARE, BY PROPERTY TYPE, 2024 VS. 2029
4.6 MARKET SHARE, BY APPLICATION, 2024 VS. 2029
4.7 MARKET SHARE FOR CHRONIC WOUNDS, BY TYPE, 2024 VS. 2029
4.8 MARKET SHARE FOR ACUTE WOUNDS, BY TYPE, 2024 VS. 2029
4.9 MARKET SHARE, BY END USER, 2024 VS. 2029
4.10 MARKET SHARE FOR HOSPITALS & CLINICS, BY TYPE, 2024 VS. 2029
4.11 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. - 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic wounds
5.2.1.2 Growing geriatric population
5.2.1.3 Increasing number of surgical procedures worldwide
5.2.1.4 Increasing incidence of burn injuries
5.2.1.5 Advancements in bioactive dressing technology
5.2.2 RESTRAINTS
5.2.2.1 High costs of bioactive dressing products
5.2.2.2 Limited reimbursement policies
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential of emerging countries
5.2.3.2 New product development
5.2.3.3 Strategic collaboration between market players
5.2.4 CHALLENGES
5.2.4.1 Difficult regulatory approval process
5.2.4.2 Lack of awareness and education
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS
5.3.2 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION
5.4 PATENT ANALYSIS
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 BIOACTIVE DRESSINGS MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 DEGREE OF COMPETITION
5.9 KEY STAKEHOLDERS & BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.10 REGULATORY ANALYSIS
5.10.1 REGULATORY LANDSCAPE
5.10.1.1 North America
5.10.1.1.1 US
5.10.1.1.2 Canada
5.10.1.2 Europe
5.10.1.3 Asia Pacific
5.10.1.3.1 China
5.10.1.3.2 Japan
5.10.1.3.3 India
5.10.1.4 Latin America
5.10.1.4.1 Brazil
5.10.1.4.2 Mexico
5.10.1.5 Middle East
5.10.1.6 Africa
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Kollagen technology
5.12.2 COMPLEMENTARY TECHNOLOGIES
5.12.2.1 Bioactive microfiber gelling technology
5.12.3 ADJACENT TECHNOLOGIES
5.12.3.1 Kerecis intact fish skin technology
5.13 KEY CONFERENCES & EVENTS, 2024-2025
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF AI ON MARKET

6 BIOACTIVE DRESSINGS MARKET, BY PRODUCT (Page No. - 89)
6.1 INTRODUCTION
6.2 BIOACTIVE DRESSINGS
6.2.1 COLLAGEN DRESSINGS
6.2.1.1 Unique healing properties and biocompatibility to drive growth
6.2.2 ALGINATE DRESSINGS
6.2.2.1 Excellent absorption capacity to boost demand for alginate dressings
6.2.3 CHITOSAN DRESSINGS
6.2.3.1 Rising need for effective, natural wound healing options to support market growth
6.2.4 HONEY DRESSINGS
6.2.4.1 Effective and natural wound care management to fuel growth
6.2.5 OTHER BIOACTIVE DRESSINGS
6.3 SKIN SUBSTITUTES
6.3.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS
6.3.1.1 High efficacy of human donor tissue-derived products to support market demand
6.3.2 ACELLULAR ANIMAL-DERIVED PRODUCTS
6.3.2.1 Recognition of importance of ECM in wound treatment to boost development of acellular wound care biologics
6.3.3 BIOSYNTHETIC PRODUCTS
6.3.3.1 Increased bioburden of infected wounds to stimulate market growth

7 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE (Page No. - 119)
7.1 INTRODUCTION
7.2 NON-ANTIMICROBIAL DRESSINGS
7.2.1 COST-EFFECTIVENESS COMPARED TO ANTIMICROBIAL DRESSINGS TO BOOST MARKET
7.3 ANTIMICROBIAL DRESSINGS
7.3.1 EFFECTIVENESS IN PREVENTING AND MANAGING INFECTIONS TO DRIVE GROWTH

8 BIOACTIVE DRESSINGS MARKET, BY APPLICATION (Page No. - 127)
8.1 INTRODUCTION
8.2 CHRONIC WOUNDS
8.2.1 DIABETIC FOOT ULCERS
8.2.1.1 Increasing prevalence of diabetes to drive growth
8.2.2 PRESSURE ULCERS
8.2.2.1 Growing geriatric population to drive demand for bioactive dressings
8.2.3 VENOUS LEG ULCERS
8.2.3.1 Rising prevalence of obesity to boost adoption
8.2.4 OTHER CHRONIC WOUNDS
8.3 ACUTE WOUNDS
8.3.1 SURGICAL WOUNDS
8.3.1.1 Rising volume of surgical procedures to support market growth
8.3.2 TRAUMATIC WOUNDS
8.3.2.1 Increasing number of road accidents to drive growth
8.3.3 BURNS
8.3.3.1 High incidence of burn injuries to propel market growth

9 BIOACTIVE DRESSINGS MARKET, BY END USER (Page No. - 156)
9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
9.2.1 INPATIENT SETTINGS
9.2.1.1 Increasing hospital admissions due to HAIs to drive growth
9.2.2 OUTPATIENT SETTINGS
9.2.2.1 Rising costs of inpatient facilities to drive demand for outpatient care settings
9.3 HOME CARE SETTINGS
9.3.1 LOW COSTS AND CONVENIENCE TO DRIVE GROWTH
9.4 LONG-TERM CARE FACILITIES
9.4.1 GROWTH IN GERIATRIC & VULNERABLE POPULATIONS TO BOOST DEMAND FOR BETTER LONG-TERM CARE
9.5 OTHER END USERS

10 BIOACTIVE DRESSINGS MARKET, BY REGION (Page No. - 177)
10.1 INTRODUCTIONS
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising prevalence of chronic diseases to drive market
10.2.2 CANADA
10.2.2.1 Growing awareness about diabetes and its associated complications to fuel market
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Rising focus on medical technology clusters to boost market
10.3.2 UK
10.3.2.1 Increasing prevalence of surgeries to aid growth
10.3.3 FRANCE
10.3.3.1 Surge in elderly population to propel market
10.3.4 ITALY
10.3.4.1 Improved life expectancy to support growth
10.3.5 SPAIN
10.3.5.1 Increasing median age to augment growth
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Growing incidence of diabetic foot ulceration to drive market
10.4.2 JAPAN
10.4.2.1 Expanding hospital infrastructure to fuel market
10.4.3 INDIA
10.4.3.1 Booming medical tourism in India to boost market
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Presence of large patient population to stimulate growth
10.5.2 MEXICO
10.5.2.1 Growing awareness about effective wound care approaches to support growth
10.5.3 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO AID MARKET GROWTH
10.7 GCC COUNTRIES
10.7.1 FAVORABLE HEALTHCARE INFRASTRUCTURE AND INITIATIVES TO BOOST MARKET

11 COMPETITIVE LANDSCAPE (Page No. - 260)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Product footprint
11.5.5.3 Property footprint
11.5.5.4 Application footprint
11.5.5.5 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 277)
12.1 KEY PLAYERS
12.1.1 SMITH+NEPHEW
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Expansions
12.1.1.3.2 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 ORGANOGENESIS INC.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.3.2 Other developments
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 MIMEDX GROUP, INC.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.3.2 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 3M
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Other developments
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 CARDINAL HEALTH
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 MnM view
12.1.5.3.1 Key strengths
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses and competitive threats
12.1.6 B. BRAUN SE
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 MÖLNLYCKE AB
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 CONVATEC INC.
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product approvals
12.1.8.3.2 Deals
12.1.9 PAUL HARTMANN AG
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 COLOPLAST CORP.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Deals
12.1.11 INTEGRA LIFESCIENCES CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 ESSITY AKTIEBOLAG
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.13 COVALON TECHNOLOGIES LTD.
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Other developments
12.1.14 SANARA MEDTECH
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches
12.1.14.3.2 Deals
12.2 OTHER PLAYERS
12.2.1 MEDLINE INDUSTRIES, INC.
12.2.2 HOLLISTER INCORPORATED
12.2.3 L&R GROUP
12.2.4 DERMARITE INDUSTRIES, LLC
12.2.5 BIOTISSUE
12.2.6 LIFENET HEALTH
12.2.7 ADVANCIS MEDICAL
12.2.8 HUMAN BIOSCIENCES
12.2.9 AMERX HEALTH CARE
12.2.10 GENTELL
12.2.11 AXIO BIOSOLUTIONS PVT. LTD.

13 APPENDIX (Page No. - 336)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES (439 TABLES)
TABLE 1 RISK ASSESSMENT ANALYSIS
TABLE 2 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
TABLE 3 BIOACTIVE DRESSINGS MARKET: RECENT PRODUCT LAUNCHES
TABLE 4 BIOACTIVE DRESSINGS INDUSTRY: RECENT COLLABORATIONS OF NOTE
TABLE 5 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS, BY PRODUCT, 2021-2023
TABLE 6 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION (2023)
TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS (%)
TABLE 9 KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 IMPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 15 EXPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 16 BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
TABLE 17 MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 18 MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 19 MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 20 NORTH AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 21 EUROPE: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 23 LATIN AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 24 KEY PRODUCTS IN COLLAGEN DRESSINGS SEGMENT
TABLE 25 COLLAGEN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 26 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 27 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 29 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 30 KEY PRODUCTS IN ALGINATE DRESSINGS SEGMENT
TABLE 31 ALGINATE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 32 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 33 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 35 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 36 KEY PRODUCTS IN CHITOSAN DRESSINGS SEGMENT
TABLE 37 CHITOSAN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 38 NORTH AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 39 EUROPE: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 41 LATIN AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 42 KEY PRODUCTS IN HONEY DRESSINGS SEGMENT
TABLE 43 HONEY DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 44 NORTH AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 45 EUROPE: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 47 LATIN AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 48 OTHER BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 49 NORTH AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 EUROPE: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 51 ASIA PACIFIC: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 52 LATIN AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 53 KEY PRODUCTS IN SKIN SUBSTITUTES SEGMENT
TABLE 54 SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 55 SKIN SUBSTITUTES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 56 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 57 EUROPE: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 58 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 59 LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 60 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS SEGMENT
TABLE 61 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 62 NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 63 EUROPE: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 64 ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 65 LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 66 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS SEGMENT
TABLE 67 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 69 EUROPE: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 71 LATIN AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 72 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 73 NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 74 EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 76 LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 77 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 78 KEY PRODUCTS IN NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET
TABLE 79 MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 80 NORTH AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 81 EUROPE: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 LATIN AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 84 KEY PRODUCTS IN ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET
TABLE 85 ANTIMICROBIAL BIOACTIVE DRESSINGS INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
TABLE 86 NORTH AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 87 EUROPE: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 88 ASIA PACIFIC: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 89 LATIN AMERICA: MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 90 BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 91 BIOACTIVE DRESSINGS INDUSTRY FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 92 MARKET FOR CHRONIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 94 EUROPE: MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 96 LATIN AMERICA: MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 97 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021
TABLE 98 NUMBER OF PATIENTS DEVELOPING NEW CASES OF DIABETIC FOOT ULCERS, 2022-2029 (THOUSAND)
TABLE 99 BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 100 NORTH AMERICA: BIOACTIVE DRESSINGS INDUSTRY FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 101 EUROPE: MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 102 ASIA PACIFIC: MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 103 LATIN AMERICA: MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 104 MARKET FOR PRESSURE ULCERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 105 NORTH AMERICA: MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 EUROPE: MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 107 ASIA PACIFIC: MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 108 LATIN AMERICA: MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 109 MARKET FOR VENOUS LEG ULCERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 110 NORTH AMERICA: MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 111 EUROPE: MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 LATIN AMERICA: MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 114 MARKET FOR OTHER CHRONIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 116 EUROPE: MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 118 LATIN AMERICA: MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 119 BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 120 BIOACTIVE DRESSINGS INDUSTRY FOR ACUTE WOUNDS, BY REGION, 2022-2029 (USD MILLION)
TABLE 121 NORTH AMERICA: MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 EUROPE: MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 123 ASIA PACIFIC: MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 124 LATIN AMERICA: MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 125 MARKET FOR SURGICAL WOUNDS, BY REGION, 2022-2029 (USD MILLION)
TABLE 126 NORTH AMERICA: MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 EUROPE: MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 129 LATIN AMERICA: MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 130 MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2022-2029 (USD MILLION)
TABLE 131 NORTH AMERICA: MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 132 EUROPE: MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 134 LATIN AMERICA: MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 135 MARKET FOR BURNS, BY REGION, 2022-2029 (USD MILLION)
TABLE 136 NORTH AMERICA: MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 137 EUROPE: MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 139 LATIN AMERICA: MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 140 MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 141 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2022
TABLE 142 BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 143 BIOACTIVE DRESSINGS INDUSTRY FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 144 NORTH AMERICA: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 145 EUROPE: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 147 LATIN AMERICA: MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 148 BIOACTIVE DRESSINGS INDUSTRY FOR INPATIENT SETTINGS, BY REGION, 2022-2029 (USD MILLION)
TABLE 149 NORTH AMERICA: MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 150 EUROPE: MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 151 ASIA PACIFIC: MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 152 LATIN AMERICA: MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 153 MARKET FOR OUTPATIENT SETTINGS, BY REGION, 2022-2029 (USD MILLION)
TABLE 154 NORTH AMERICA: MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 155 EUROPE: MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 156 ASIA PACIFIC: MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 157 LATIN AMERICA: MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 158 MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
TABLE 159 NORTH AMERICA: MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 160 EUROPE: MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 162 LATIN AMERICA: MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 163 MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 165 EUROPE: MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 168 MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 169 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 170 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 173 BIOACTIVE DRESSINGS INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
TABLE 174 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 175 NORTH AMERICA: MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 176 NORTH AMERICA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 177 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 179 NORTH AMERICA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 180 NORTH AMERICA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 181 NORTH AMERICA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 182 NORTH AMERICA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 183 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 184 US: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 185 US: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 186 US: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 187 US: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 188 US: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 189 US: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 190 US: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 191 US: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 192 US: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 193 DIABETES INCIDENCE IN CANADA, 2023 VS. 2032
TABLE 194 CANADA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 195 CANADA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 196 CANADA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 197 CANADA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 198 CANADA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 199 CANADA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 200 CANADA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 201 CANADA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 202 CANADA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 203 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
TABLE 204 PREVALENCE OF DIABETES IN EUROPE, 2021 VS. 2045
TABLE 205 EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 206 EUROPE: MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 207 EUROPE: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 208 EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 209 EUROPE: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 210 EUROPE: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 211 EUROPE: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 212 EUROPE: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 213 EUROPE: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 214 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 215 GERMANY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 216 GERMANY: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 217 GERMANY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 218 GERMANY: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 219 GERMANY: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 220 GERMANY: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 221 GERMANY: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 222 GERMANY: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 223 GERMANY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 224 UK: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 225 UK: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 226 UK: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 227 UK: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 228 UK: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 229 UK: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 230 UK: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 231 UK: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 232 UK: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 233 FRANCE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 234 FRANCE: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 235 FRANCE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 236 FRANCE: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 237 FRANCE: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 238 FRANCE: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 239 FRANCE: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 240 FRANCE: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 241 FRANCE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 242 ITALY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 243 ITALY: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 244 ITALY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 245 ITALY: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 246 ITALY: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 247 ITALY: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 248 ITALY: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 249 ITALY: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 250 ITALY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 251 SPAIN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 252 SPAIN: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 253 SPAIN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 254 SPAIN: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 255 SPAIN: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 256 SPAIN: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 257 SPAIN: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 258 SPAIN: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 259 SPAIN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 260 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 261 REST OF EUROPE: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 262 REST OF EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 263 REST OF EUROPE: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 264 REST OF EUROPE: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 265 REST OF EUROPE: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 266 REST OF EUROPE: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 267 REST OF EUROPE: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 268 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 269 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 270 ASIA PACIFIC: MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 271 ASIA PACIFIC: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 272 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 274 ASIA PACIFIC: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 276 ASIA PACIFIC: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 277 ASIA PACIFIC: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 278 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 279 CHINA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 280 CHINA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 281 CHINA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 282 CHINA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 283 CHINA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 284 CHINA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 285 CHINA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 286 CHINA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 287 CHINA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 288 JAPAN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 289 JAPAN: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 290 JAPAN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 291 JAPAN: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 292 JAPAN: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 293 JAPAN: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 294 JAPAN: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 295 JAPAN: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 296 JAPAN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 297 INDIA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 298 INDIA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 299 INDIA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION)
TABLE 300 INDIA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 301 INDIA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 302 INDIA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 303 INDIA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 304 INDIA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 305 INDIA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 306 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 307 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2022-2029 (USD MILLION),
TABLE 308 REST OF ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 309 REST OF ASIA PACIFIC: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 310 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 311 REST OF ASIA PACIFIC: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 312 REST OF ASIA PACIFIC: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 315 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 316 LATIN AMERICA: MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 317 LATIN AMERICA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 318 LATIN AMERICA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION)
TABLE 319 LATIN AMERICA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 320 LATIN AMERICA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 321 LATIN AMERICA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 322 LATIN AMERICA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 323 LATIN AMERICA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 324 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 325 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 326 BRAZIL: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 327 BRAZIL: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 328 BRAZIL: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 329 BRAZIL: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 330 BRAZIL: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 331 BRAZIL: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 332 BRAZIL: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 333 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 334 MEXICO: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 335 MEXICO: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 336 MEXICO: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 337 MEXICO: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 338 MEXICO: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 339 MEXICO: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 340 MEXICO: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 341 MEXICO: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 342 MEXICO: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 343 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 344 REST OF LATIN AMERICA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 345 REST OF LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 346 REST OF LATIN AMERICA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 347 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 348 REST OF LATIN AMERICA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 349 REST OF LATIN AMERICA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 350 REST OF LATIN AMERICA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 351 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 352 DIABETES IN MIDDLE EAST & NORTH AFRICA, 2021
TABLE 353 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 356 MIDDLE EAST & AFRICA: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 357 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 358 MIDDLE EAST & AFRICA: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 359 MIDDLE EAST & AFRICA: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 360 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 361 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 362 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 363 GCC COUNTRIES: MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 364 GCC COUNTRIES: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 365 GCC COUNTRIES: MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION)
TABLE 366 GCC COUNTRIES: MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 367 GCC COUNTRIES: MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 368 GCC COUNTRIES: MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 369 GCC COUNTRIES: MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 370 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 371 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BIOACTIVE DRESSINGS INDUSTRY
TABLE 372 BIOACTIVE DRESSINGS MARKET: DEGREE OF COMPETITION
TABLE 373 BIOACTIVE DRESSINGS INDUSTRY RANKING, BY KEY PLAYER, 2023
TABLE 374 GLOBAL SKIN SUBSTITUTES MARKET RANKING, BY KEY PLAYER, 2023
TABLE 375 MARKET: PRODUCT FOOTPRINT
TABLE 376 MARKET: PROPERTY FOOTPRINT
TABLE 377 MARKET: APPLICATION FOOTPRINT
TABLE 378 MARKET: REGION FOOTPRINT
TABLE 379 MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 380 MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 381 MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JULY 2024
TABLE 382 MARKET: DEALS, JANUARY 2021-JULY 2024
TABLE 383 MARKET: EXPANSIONS, JANUARY 2021-JULY 2024
TABLE 384 MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
TABLE 385 SMITH+NEPHEW: COMPANY OVERVIEW
TABLE 386 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 387 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-JULY 2024
TABLE 388 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
TABLE 389 ORGANOGENESIS INC.: COMPANY OVERVIEW
TABLE 390 ORGANOGENESIS INC.: PRODUCTS OFFERED
TABLE 391 ORGANOGENESIS INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
TABLE 392 ORGANOGENESIS INC.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
TABLE 393 MIMEDX GROUP, INC.: COMPANY OVERVIEW
TABLE 394 MIMEDX GROUP, INC.: PRODUCTS OFFERED
TABLE 395 MIMEDX GROUP, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JULY 2024
TABLE 396 MIMEDX GROUP, INC.: DEALS, JANUARY 2021-JULY 2024
TABLE 397 3M: COMPANY OVERVIEW
TABLE 398 3M: PRODUCTS OFFERED
TABLE 399 3M: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
TABLE 400 CARDINAL HEALTH: COMPANY OVERVIEW
TABLE 401 CARDINAL HEALTH: PRODUCTS OFFERED
TABLE 402 B. BRAUN SE: COMPANY OVERVIEW
TABLE 403 B. BRAUN SE: PRODUCTS OFFERED
TABLE 404 MÖLNLYCKE AB: COMPANY OVERVIEW
TABLE 405 MÖLNLYCKE AB: PRODUCTS OFFERED
TABLE 406 CONVATEC INC.: COMPANY OVERVIEW
TABLE 407 CONVATEC INC.: PRODUCTS OFFERED
TABLE 408 CONVATEC INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024
TABLE 409 CONVATEC INC.: DEALS, JANUARY 2021-JULY 2024
TABLE 410 PAUL HARTMANN AG: COMPANY OVERVIEW
TABLE 411 PAUL HARTMANN AG: PRODUCTS OFFERED
TABLE 412 COLOPLAST CORP.: COMPANY OVERVIEW
TABLE 413 COLOPLAST CORP.: PRODUCTS OFFERED
TABLE 414 COLOPLAST CORP.: DEALS, JANUARY 2021-JULY 2024
TABLE 415 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 416 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 417 INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021-JULY 2024
TABLE 418 ESSITY AKTIEBOLAG: COMPANY OVERVIEW
TABLE 419 ESSITY AKTIEBOLAG: PRODUCTS OFFERED
TABLE 420 ESSITY AKTIEBOLAG: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024
TABLE 421 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021-JULY 2024
TABLE 422 COVALON TECHNOLOGIES LTD.: COMPANY OVERVIEW
TABLE 423 COVALON TECHNOLOGIES LTD.: PRODUCTS OFFERED
TABLE 424 COVALON TECHNOLOGIES LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024
TABLE 425 SANARA MEDTECH: COMPANY OVERVIEW
TABLE 426 SANARA MEDTECH: PRODUCTS OFFERED
TABLE 427 SANARA MEDTECH: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024
TABLE 428 SANARA MEDTECH: DEALS, JANUARY 2021-JULY 2024
TABLE 429 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 430 HOLLISTER INCORPORATED: COMPANY OVERVIEW
TABLE 431 L&R GROUP: COMPANY OVERVIEW
TABLE 432 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW
TABLE 433 BIOTISSUE: COMPANY OVERVIEW
TABLE 434 LIFENET HEALTH: COMPANY OVERVIEW
TABLE 435 ADVANCIS MEDICAL: COMPANY OVERVIEW
TABLE 436 HUMAN BIOSCIENCES: COMPANY OVERVIEW
TABLE 437 AMERX HEALTH CARE: COMPANY OVERVIEW
TABLE 438 GENTELL: COMPANY OVERVIEW
TABLE 439 AXIO BIOSOLUTIONS PVT. LTD.: COMPANY OVERVIEW

LIST OF FIGURES (57 FIGURES)
FIGURE 1 MARKETS COVERED
FIGURE 2 RESEARCH DESIGN METHODOLOGY
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 BIOACTIVE DRESSINGS MARKET: TOP-DOWN APPROACH
FIGURE 8 DATA TRIANGULATION METHODOLOGY
FIGURE 9 BIOACTIVE DRESSINGS INDUSTRY, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 10 BIOACTIVE DRESSINGS INDUSTRY, BY PROPERTY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 11 BIOACTIVE DRESSINGS INDUSTRY, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 12 BIOACTIVE DRESSINGS INDUSTRY, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 13 BIOACTIVE DRESSINGS INDUSTRY, BY REGION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 GROWING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
FIGURE 15 SKIN SUBSTITUTES SEGMENT TO DOMINATE MARKET IN 2029
FIGURE 16 COLLAGEN DRESSINGS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 17 HUMAN DONOR TISSUE-DERIVED PRODUCTS TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 18 NON-ANTIMICROBIAL DRESSINGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 19 CHRONIC WOUNDS SEGMENT TO DOMINATE MARKET IN 2029
FIGURE 20 DIABETIC FOOT ULCERS SEGMENT TO LEAD MARKET IN 2029
FIGURE 21 SURGICAL WOUNDS SEGMENT TO LEAD MARKET IN 2029
FIGURE 22 HOSPITALS & CLINICS SEGMENT TO DOMINATE MARKET IN 2029
FIGURE 23 INPATIENT SETTINGS SEGMENT TO DOMINATE MARKET IN 2029
FIGURE 24 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BIOACTIVE DRESSINGS MARKET DURING FORECAST PERIOD
FIGURE 25 BIOACTIVE DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 26 PATENT ANALYSIS FOR BIOACTIVE DRESSING PRODUCTS (JANUARY 2014-DECEMBER 2023)
FIGURE 27 BIOACTIVE DRESSINGS MARKET: VALUE CHAIN ANALYSIS
FIGURE 28 BIOACTIVE DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 29 BIOACTIVE DRESSINGS MARKET: ECOSYSTEM ANALYSIS
FIGURE 30 BIOACTIVE DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS
FIGURE 32 KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS
FIGURE 33 REVENUE SHIFT IN BIOACTIVE DRESSINGS MARKET
FIGURE 34 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET SNAPSHOT
FIGURE 35 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET (2021-2023)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET (2023)
FIGURE 38 BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 39 BIOACTIVE DRESSINGS MARKET: COMPANY FOOTPRINT
FIGURE 40 BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 41 EV/EBITDA OF KEY VENDORS
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 43 BIOACTIVE DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
FIGURE 45 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2023)
FIGURE 46 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2023)
FIGURE 47 3M: COMPANY SNAPSHOT (2023)
FIGURE 48 CARDINAL HEALTH: COMPANY SNAPSHOT (2023)
FIGURE 49 B. BRAUN SE: COMPANY SNAPSHOT (2023)
FIGURE 50 MÖLNLYCKE AB: COMPANY SNAPSHOT (2023)
FIGURE 51 CONVATEC INC.: COMPANY SNAPSHOT (2023)
FIGURE 52 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023)
FIGURE 53 COLOPLAST CORP.: COMPANY SNAPSHOT (2023)
FIGURE 54 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 55 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2023)
FIGURE 56 COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)
FIGURE 57 SANARA MEDTECH: COMPANY SNAPSHOT (2023)